- Home
- OCEAW vs UBCP Comparison
OCEAW vs UBCP Comparison
Compare OCEAW & UBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- UBCP
- Stock Information
- Founded
- OCEAW N/A
- UBCP 1902
- Country
- OCEAW United States
- UBCP United States
- Employees
- OCEAW 7
- UBCP N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- UBCP Major Banks
- Sector
- OCEAW Health Care
- UBCP Finance
- Exchange
- OCEAW Nasdaq
- UBCP Nasdaq
- Market Cap
- OCEAW N/A
- UBCP N/A
- IPO Year
- OCEAW 2021
- UBCP N/A
- Fundamental
- Price
- OCEAW $0.03
- UBCP $13.00
- Analyst Decision
- OCEAW
- UBCP
- Analyst Count
- OCEAW 0
- UBCP 0
- Target Price
- OCEAW N/A
- UBCP N/A
- AVG Volume (30 Days)
- OCEAW N/A
- UBCP 4.4K
- Earning Date
- OCEAW N/A
- UBCP 02-07-2025
- Dividend Yield
- OCEAW N/A
- UBCP 6.58%
- EPS Growth
- OCEAW N/A
- UBCP N/A
- EPS
- OCEAW N/A
- UBCP 1.27
- Revenue
- OCEAW N/A
- UBCP $28,831,592.00
- Revenue This Year
- OCEAW N/A
- UBCP N/A
- Revenue Next Year
- OCEAW N/A
- UBCP $3.00
- P/E Ratio
- OCEAW N/A
- UBCP $10.24
- Revenue Growth
- OCEAW N/A
- UBCP N/A
- 52 Week Low
- OCEAW N/A
- UBCP $11.40
- 52 Week High
- OCEAW N/A
- UBCP $15.50
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- UBCP 51.04
- Support Level
- OCEAW N/A
- UBCP $12.65
- Resistance Level
- OCEAW N/A
- UBCP $13.46
- Average True Range (ATR)
- OCEAW 0.00
- UBCP 0.45
- MACD
- OCEAW 0.00
- UBCP 0.01
- Stochastic Oscillator
- OCEAW 0.00
- UBCP 61.98
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.